Virios Therapeutics, Inc.
VIRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,563,379 | $270,010 | $65,314 | $1,065,152 |
| - Cash | $0 | $3,317 | $7,031 | $14,008 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $4,563,379 | $266,693 | $58,283 | $1,051,144 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12,227,248 | $151 | -$12,315 | -$15,641 |
| % Margin | – | – | – | – |
| Net Income | -$12,863,829 | -$5,296 | -$12,180 | -$15,960 |
| % Margin | – | – | – | – |
| EPS Diluted | -12.52 | -0.28 | -1.1 | -1.92 |
| % Growth | -4,371.4% | 74.5% | 42.7% | – |
| Operating Cash Flow | -$8,790,805 | -$4,870 | -$11,468 | -$15,690 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8,790,805 | -$4,870 | -$11,468 | -$15,690 |